227 related articles for article (PubMed ID: 35703984)
41. Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits.
Santiago LG; Morgado FJ; Baptista MS; Gonçalo M
Contact Dermatitis; 2020 May; 82(5):290-296. PubMed ID: 31900951
[TBL] [Abstract][Full Text] [Related]
42. DRESS syndrome in a patient with cystic fibrosis: A case report.
Gohy S; Froidure A; Lebecque P
Pediatr Pulmonol; 2017 Apr; 52(4):E18-E21. PubMed ID: 27740720
[TBL] [Abstract][Full Text] [Related]
43. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
44. Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.
Ramírez E; Medrano-Casique N; Tong HY; Bellón T; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Trigo E; Muñoz M; Borobia AM; Carcas AJ; Frías J
Br J Clin Pharmacol; 2017 Feb; 83(2):400-415. PubMed ID: 27543764
[TBL] [Abstract][Full Text] [Related]
45. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
[TBL] [Abstract][Full Text] [Related]
46. Anti-tubercular therapy causing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
Saxena P; Chadha D; Goyal R
J R Coll Physicians Edinb; 2020 Dec; 50(4):414-415. PubMed ID: 33469620
[TBL] [Abstract][Full Text] [Related]
47. Two cases with HSS/DRESS syndrome developing after prosthetic joint surgery: does vancomycin-laden bone cement play a role in this syndrome?
Güner MD; Tuncbilek S; Akan B; Caliskan-Kartal A
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26021379
[TBL] [Abstract][Full Text] [Related]
48. Clinical, biochemical, and serologic predictors of drug reaction with eosinophilia and systemic symptoms syndrome: A prospective case-control study.
Choudhary R; Vinay K; Srivastava N; Bishnoi A; Kamat D; Parsad D; Bhatia A; Kumaran MS
J Am Acad Dermatol; 2021 Oct; 85(4):901-909. PubMed ID: 33785387
[TBL] [Abstract][Full Text] [Related]
49. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?
Almudimeegh A; Rioux C; Ferrand H; Crickx B; Yazdanpanah Y; Descamps V
Br J Dermatol; 2014 Oct; 171(4):895-8. PubMed ID: 24773172
[TBL] [Abstract][Full Text] [Related]
50. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Probably Related to Cefpodoxime: A Case Report.
Babu T; Panachiyil GM; Sebastian J; Shastry V
J Pharm Pract; 2021 Feb; 34(1):163-165. PubMed ID: 31382812
[TBL] [Abstract][Full Text] [Related]
51. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
52. Severe enterocolitis associated with antiepileptic-induced drug reaction with eosinophilia and systemic symptoms.
Swanson EA; Low L; Naini BV
Hum Pathol; 2014 Sep; 45(9):1973-7. PubMed ID: 24935058
[TBL] [Abstract][Full Text] [Related]
53. Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report.
Hyser E
J Med Case Rep; 2022 Sep; 16(1):336. PubMed ID: 36059007
[TBL] [Abstract][Full Text] [Related]
54. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692
[TBL] [Abstract][Full Text] [Related]
55. An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Danjuma MI; Naseralallah LMA; AbouJabal B; Mohamed MF; Abubeker IY; Jabbar LA; Elzouki A
Sci Rep; 2021 Sep; 11(1):17887. PubMed ID: 34504198
[TBL] [Abstract][Full Text] [Related]
56. Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use.
Bai M; Govindaraj V; Kottaisamy R; Vijayarangam N
J Postgrad Med; 2022; 68(2):102-105. PubMed ID: 35466662
[TBL] [Abstract][Full Text] [Related]
57. Vancomycin-associated drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: masquerading under the guise of sepsis.
Maxfield L; Schlick T; Macri A; Thatcher J
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29054953
[TBL] [Abstract][Full Text] [Related]
58. [Drug reaction with eosinophilia and systemic symptoms].
Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
[TBL] [Abstract][Full Text] [Related]
59. Clinical features, treatment outcomes and prognostic factors of allopurinol-induced DRESS in 52 patients.
Liu Q; Zhao S; Chen W
J Clin Pharm Ther; 2022 Sep; 47(9):1368-1378. PubMed ID: 35971667
[TBL] [Abstract][Full Text] [Related]
60. A Rare Case of Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Leading to Hemodialysis and Multiple Infections: A Case Report and Literature Review.
Iwashige Y; Yamamoto S; Ohue K; Sugimoto H; Yabumoto H; Kamimatsuse R; Kamido H; Akagi R; Matsumoto M; Yamamoto-Nonaka K; Minamiguchi S; Yanagita M
Intern Med; 2024 Apr; 63(8):1131-1138. PubMed ID: 37612089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
